Bros Advisors Llc Baker is Director & 10% at GENOMIC HEALTH INC (GHDX). They have made 5 open-market trades across 2 companies since 2012, most recently 2013-06-05.
CIK 0001263508
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $63.5M since 2012, never a sale. Across 5 scored buys the stock is down 1.4% at ninety days, and 1.7 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 20% | 20% |
| Avg Move | -14.7% | -1.4% | -1.4% |
| Alpha | -8.8% | -1.7% | -1.7% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GHDX | BUY | 2013-06-04 | 2013-06-05 | $36.16 | $13.8M | -10.0% | -1.8% | -1.8% |
| ACAD | BUY | 2013-06-03 | 2013-06-05 | $14.33 | $29.9M | -33.1% | +0.1% | +0.1% |
| GHDX | BUY | 2013-02-13 | 2013-02-14 | $28.48 | $1.5M | -10.0% | -1.8% | -1.8% |
| GHDX | BUY | 2012-05-14 | 2012-05-16 | $33.88 | $12.7M | -10.0% | -1.8% | -1.8% |
| GHDX | BUY | 2012-05-04 | 2012-05-08 | $28.45 | $5.6M | -10.0% | -1.8% | -1.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.